Your browser doesn't support javascript.
loading
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial.
Shaheen, Montaser F; Tse, Julie Y; Sokol, Ethan S; Masterson, Margaret; Bansal, Pranshu; Rabinowitz, Ian; Tarleton, Christy A; Dobroff, Andrey S; Smith, Tracey L; Bocklage, Thèrése J; Mannakee, Brian K; Gutenkunst, Ryan N; Bischoff, Joyce; Ness, Scott A; Riedlinger, Gregory M; Groisberg, Roman; Pasqualini, Renata; Ganesan, Shridar; Arap, Wadih.
Affiliation
  • Shaheen MF; University of Arizona Cancer Center, Tucson, United States.
  • Tse JY; Division of Hematology/Oncology, Department of Medicine, University of Arizona College of Medicine, Tucson, United States.
  • Sokol ES; Foundation Medicine, Inc, Cambridge, United States.
  • Masterson M; Foundation Medicine, Inc, Cambridge, United States.
  • Bansal P; Rutgers Cancer Institute of New Jersey, New Brunswick, United States.
  • Rabinowitz I; Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, United States.
  • Tarleton CA; University of New Mexico Comprehensive Cancer Center, Albuquerque, United States.
  • Dobroff AS; Division of Hematology/Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, United States.
  • Smith TL; University of New Mexico Comprehensive Cancer Center, Albuquerque, United States.
  • Bocklage TJ; Division of Hematology/Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, United States.
  • Mannakee BK; University of New Mexico Comprehensive Cancer Center, Albuquerque, United States.
  • Gutenkunst RN; Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, United States.
  • Bischoff J; University of New Mexico Comprehensive Cancer Center, Albuquerque, United States.
  • Ness SA; Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, United States.
  • Riedlinger GM; Rutgers Cancer Institute of New Jersey, Newark, United States.
  • Groisberg R; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, United States.
  • Pasqualini R; University of New Mexico Comprehensive Cancer Center, Albuquerque, United States.
  • Ganesan S; Department of Pathology, University of Kentucky College of Medicine and Markey Cancer Center, Lexington, United States.
  • Arap W; University of Arizona Cancer Center, Tucson, United States.
Elife ; 112022 07 05.
Article in En | MEDLINE | ID: mdl-35787784
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thiazoles / Lymphatic Abnormalities / Class I Phosphatidylinositol 3-Kinases / GTP Phosphohydrolases / Lymphangioma / Membrane Proteins / Antineoplastic Agents Language: En Journal: Elife Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thiazoles / Lymphatic Abnormalities / Class I Phosphatidylinositol 3-Kinases / GTP Phosphohydrolases / Lymphangioma / Membrane Proteins / Antineoplastic Agents Language: En Journal: Elife Year: 2022 Type: Article Affiliation country: United States